NMRA compared with SEER: revenue, margins and what each company keeps, and the suppliers and customers both name

NMRANeumora Therapeutics, Inc.

Mkt capRevenueRevenue

SEERSeer, Inc.

Mkt capRevenueRevenue

Compare

NMRANeumora Therapeutics, Inc.

SEERSeer, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NMRA1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±30.0%▼−7.51%×0.25

SEER1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.8%▼−0.93%×0.03

= impliedNMRA realized, solidSEER realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

NMRANeumora Therapeutics, Inc.

0.42▲+13.67%

Mkt cap$69.0MRevenue—Revenue—

SEERSeer, Inc.

1.70▲+1.07%

Regular sessionSep 2 '83

Mkt cap$93.0MRevenue$3MQ2 FY26Revenue$17MFY25

Compare

Regular sessionSep 2 '83

NMRANeumora Therapeutics, Inc.

SEERSeer, Inc.

0.42▲+13.67%

Price

1.70▲+1.07%

$69.0M

Mkt cap

$93.0M

—

Revenue

$3MQ2 FY26

—

Revenue

$17MFY25

NMRA0.42▲+13.67%vsSEER1.70▲+1.07%Regular sessionSep 2 '83